Table:
begin	end	state
1	1633	non-cytoplasmic

Input:
>AO353_22820
MAFFTAASKADFQQQLQAALAQHISEQSLPQVALFAEQFFGIISLDELTQRRLSDLAGCT
LSAWRLLERFDHAQPQVRVYNPDYERHGWQSTHTAVEVLHHDLPFLVDSVRTELNRRGYS
IHTLQTTVLSVRRGAKGELLEILPKGSQGEGILQESLMYLEIDRCAHTAELNVLSKELEQ
VLSEVRVAVADFEPMKAKVQELIEGIDKSKFAVDAEEKSEIKGFLEWLVGNHFTFLGYEE
FVVRDDKDGGHIEYDQSSFLGLTRLLRAGLTADDLRIEDYAVNYLREPTPLSFAKAAHPS
RVHRPAYPDYVSIRQIDANGKVIKECRFMGLYTSSVYGESVRVIPYIRRKVDVIEQRSGF
QSKAHLGKELAQVLEVLPRDDLFQTPVDELFSTVMSIVQIQERNKIRVFLRKDPYGRFCY
CLAYVPRDIYSTEVRQKIQQVLMDRLKASDCEFWTFFSESVLARVQLILRVDPKNRLDID
PLLLEKEVVQACRSWQDDYASLVVESFGEAQGTNVLSDFPKGFPAGYRERFAAHSAVVDM
QHLLSLSEKNPLVMSFYQPLGQVSGQRELHCKLYHADTPLALSDVLPILENLGLRVLGEF
PYRLRHSNGREFWIHDFAFTAAEGLELDIQQLNDTLQDAFVHIVRGDAENDAFNRLVLTA
GLPWRDVALLRAYARYLKQIRLGFDLGYIASTLNNHTDIARELTRLFKTRFYLARKLTSD
DLDDKQLRLEQAILSALDDVQVLNEDRILRRYLDLIKATLRTNFYQTDANGQNKSYFSFK
FNPHAIPELPKPVPKFEIFVYSPRVEGVHLRFGNVARGGLRWSDREEDFRTEVLGLVKAQ
QVKNSVIVPVGAKGGFLPRRLPLGGSRDEIAAEGIACYRIFISGLLDITDNLKDGALVPP
ANVVRHDDDDPYLVVAADKGTATFSDIANGIAIDYGFWLGDAFASGGSAGYDHKKMGITA
KGAWVGVQRHFRERGINVQEDSITVVGVGDMAGDVFGNGLLMSDKLQLVAAFNHLHIFID
PNPQPANSFAERQRLFDLPRSAWSDYDTSIMSEGGGIFSRSAKSIAISPQMKERFDIQAD
KLTPTELLNALLKAPVDLLWNGGIGTYVKASSESHADVGDKANDALRVNGNELRCKVVGE
GGNLGMTQLGRVEFGLNGGGSNTDFIDNAGGVDCSDHEVNIKILLNEVVQAGDMTEKQRN
QLLGSMTDEVGGLVLGNNYKQTQALSLAARRAYVRIAEYKRLMNDLEGRGKLDRAIEFLP
TEDQLNERVAAGHGLTRAELSVLISYSKIDLKEQLLNSLVPDDDYLTRDMETAFPPMLVS
KFSEAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSPANVAGAYVIVRDIFHL
PHWFRQIEALDYQVSADVQLELMDELMRLGRRATRWFLRSRRNEQNAARDVAHFGPHLAA
LGLKLDELLEGPTREGWQTRYQAYVAAGVPELLARMVAGTSHLYTLLPIIEAADVTGQNA
ADVAKAYFAVGSALDLTWYLQQISALPVENNWQALAREAFRDDIDWQQRAITISVLQMGN
GKQDVETRLALWMDQNQTMVERWRAMLVDIRAASGTDYAMYAVANRELLDLALSGQAVVP
VTATAIAELEPAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server